145 related articles for article (PubMed ID: 10762636)
1. Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents.
Villa R; Folini M; Perego P; Supino R; Setti E; Daidone MG; Zunino F; Zaffaroni N
Int J Oncol; 2000 May; 16(5):995-1002. PubMed ID: 10762636
[TBL] [Abstract][Full Text] [Related]
2. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
[TBL] [Abstract][Full Text] [Related]
3. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.
Asai A; Kiyozuka Y; Yoshida R; Fujii T; Hioki K; Tsubura A
Anticancer Res; 1998; 18(3A):1465-72. PubMed ID: 9673357
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and telomere lengths in various cell lines: changes of telomerase activity can be another method for chemosensitivity evaluation.
Park KH; Rha SY; Kim CH; Kim TS; Yoo NC; Kim JH; Roh JK; Noh SH; Min JS; Lee KS; Kim BS; Chung HC
Int J Oncol; 1998 Sep; 13(3):489-95. PubMed ID: 9683783
[TBL] [Abstract][Full Text] [Related]
5. A novel telomere elongation in an adriamycin-resistant stomach cancer cell line with decreased telomerase activity.
Kim JH; Lee GE; Kim JC; Lee JH; Chung IK
Mol Cells; 2002 Apr; 13(2):228-36. PubMed ID: 12018844
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity in ovarian tumors.
Murakami J; Nagai N; Ohama K; Tahara H; Ide T
Cancer; 1997 Sep; 80(6):1085-92. PubMed ID: 9305709
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents.
Smith V; Dai F; Spitz M; Peters GJ; Fiebig HH; Hussain A; Burger AM
J Chemother; 2009 Nov; 21(5):542-9. PubMed ID: 19933046
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
9. Long-term cultivation of colorectal carcinoma cells with anti-cancer drugs induces drug resistance and telomere elongation: an in vitro study.
Kuranaga N; Shinomiya N; Mochizuki H
BMC Cancer; 2001; 1():10. PubMed ID: 11518543
[TBL] [Abstract][Full Text] [Related]
10. A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line.
Furuta M; Nozawa K; Takemura M; Izuta S; Murate T; Tsuchiya M; Yoshida K; Taka N; Nimura Y; Yoshida S
Int J Cancer; 2003 May; 104(6):709-15. PubMed ID: 12640677
[TBL] [Abstract][Full Text] [Related]
11. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD
Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733
[TBL] [Abstract][Full Text] [Related]
12. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
[TBL] [Abstract][Full Text] [Related]
13. Correlation of telomerase activity and telomere length to chemosensitivity.
Kiyozuka Y
Methods Mol Med; 2005; 111():97-108. PubMed ID: 15911975
[TBL] [Abstract][Full Text] [Related]
14. Quantitative in situ evaluation of telomeres in fluorescence in situ hybridization-processed sections of cutaneous melanocytic lesions and correlation with telomerase activity.
Miracco C; Margherita De Santi M; Schürfeld K; Santopietro R; Lalinga AV; Fimiani M; Biagioli M; Brogi M; De Felice C; Luzi P; Andreassi L
Br J Dermatol; 2002 Mar; 146(3):399-408. PubMed ID: 11952539
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity in human ovarian carcinoma.
Counter CM; Hirte HW; Bacchetti S; Harley CB
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):2900-4. PubMed ID: 8159676
[TBL] [Abstract][Full Text] [Related]
16. Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells.
Biroccio A; Gabellini C; Amodei S; Benassi B; Del Bufalo D; Elli R; Antonelli A; D'Incalci M; Zupi G
Mol Pharmacol; 2003 Mar; 63(3):632-8. PubMed ID: 12606771
[TBL] [Abstract][Full Text] [Related]
17. Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor.
Incles CM; Schultes CM; Kelland LR; Neidle S
Mol Pharmacol; 2003 Nov; 64(5):1101-8. PubMed ID: 14573759
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous regression of cutaneous melanoma in sinclair swine is associated with defective telomerase activity and extensive telomere erosion.
Pathak S; Multani AS; McConkey DJ; Imam AS; Amoss MS
Int J Oncol; 2000 Dec; 17(6):1219-24. PubMed ID: 11078808
[TBL] [Abstract][Full Text] [Related]
19. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
20. Decreased telomerase activity is not a reliable indicator of chemosensitivity in testicular cancer cell lines.
Cressey TR; Tilby MJ; Newell DR
Eur J Cancer; 2002 Mar; 38(4):586-93. PubMed ID: 11872354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
